Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical

Walter E Kaufmann1, Michael V Johnston, Mary E Blue

  • 1Center for Genetic Disorders of Cognition and Behavior, Kennedy Krieger Institute and Johns Hopkins University School of Medicine, Baltimore, MD 21211, USA. kaufman@kennedykreiger.org

Brain & Development
|September 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral Features in Phelan-McDermid Syndrome: Characteristics and Genetic and Metabolic Contributions in a Cohort of 56 Individuals.

Genes·2026
Same author

Relationship Between Intellectual Disability and Behavioral Comorbidity in Children With Fragile X Syndrome.

Journal of autism and developmental disorders·2025
Same author

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder.

Developmental medicine and child neurology·2025
Same author

Publisher Correction: Rett syndrome.

Nature reviews. Disease primers·2025
Same author

The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity.

Journal of child and adolescent psychopharmacology·2025
Same author

Rett Syndrome Behaviour Questionnaire: Variability of Scores and Related Factors.

Journal of child and adolescent psychopharmacology·2025
Same journal

Association of relative age with medical consultations for developmental concerns: A nationwide birth cohort study in Japan.

Brain & development·2026
Same journal

Extending the combined N-back/Nogo paradigm: Toward subtype-sensitive and translationally meaningful ERP research in ADHD.

Brain & development·2026
Same journal

Receptor-specific dopaminergic imbalance and sensory gating in Lesch-Nyhan syndrome.

Brain & development·2026
Same journal

From weather stations to the home environment: Refining seizure prediction in pediatric drug-resistant epilepsy.

Brain & development·2026
Same journal

Pediatric GBS-myelitis overlap syndrome: Severe phenotype, treatment response, and neurological outcomes.

Brain & development·2026
Same journal

Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study.

Brain & development·2026
See all related articles

Mutations in MeCP2 cause Rett syndrome (RTT) by disrupting neuronal gene expression during critical brain development. This synaptic hypothesis explains how MeCP2 dysfunction leads to RTT

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Rett syndrome (RTT) is a neurodevelopmental disorder primarily caused by mutations in the methyl CpG-binding protein 2 (MeCP2) gene.
  • MeCP2 plays a crucial role in linking synaptic activity to neuronal gene transcription, influencing brain development and function.

Purpose of the Study:

  • To update the synaptic hypothesis of Rett syndrome by integrating diverse data on MeCP2 and RTT.
  • To propose models explaining the neurobiological basis of RTT and the phenotypic outcomes of MeCP2 dysfunction.

Main Methods:

  • Integration of data on MeCP2 neurobiology, RTT neurobiology, and MeCP2 mutational patterns.
  • Analysis of histone profiles and genotype-phenotype correlations in RTT patients.
  • Development of theoretical models for RTT pathogenesis.

Related Experiment Videos

Main Results:

  • MeCP2 dysfunction disrupts neuronal gene expression in response to synaptic signals, particularly during synaptic maturation.
  • Severe MeCP2 dysfunction during early neuronal differentiation is critical for RTT phenotype development.
  • Proposed models elucidate general and regional neuronal abnormalities in RTT.

Conclusions:

  • MeCP2 is essential for proper brain development by regulating gene expression according to neuronal activity.
  • MeCP2 dysfunction underlies RTT pathogenesis through impaired synaptic-neuronal transcription coupling.
  • The updated synaptic hypothesis provides a framework for understanding RTT and MeCP2's role in neurodevelopment.